vs
CNX Resources Corp（CNX）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是CNX Resources Corp的1.3倍（$772.1M vs $610.5M），CNX Resources Corp净利率更高（32.1% vs 12.7%，领先19.4%），CNX Resources Corp同比增速更快（347.0% vs 5.9%），Revvity自由现金流更多（$161.8M vs $122.6M），过去两年CNX Resources Corp的营收复合增速更高（32.0% vs 9.0%）
CNX资源公司是总部位于美国匹兹堡的天然气企业，业务布局覆盖阿巴拉契亚盆地，核心产区位于宾夕法尼亚州、俄亥俄州、西弗吉尼亚州的马塞勒斯和尤蒂卡页岩区，同时在弗吉尼亚州开发煤层气资产、运营甲烷捕获减排项目，拥有完善的中游业务体系，是美国规模最大的天然气生产商之一。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
CNX vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.3倍
$610.5M
营收增速更快
CNX
高出341.1%
5.9%
净利率更高
CNX
高出19.4%
12.7%
自由现金流更多
RVTY
多$39.2M
$122.6M
两年增速更快
CNX
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $610.5M | $772.1M |
| 净利润 | $196.3M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | — | 14.5% |
| 净利率 | 32.1% | 12.7% |
| 营收同比 | 347.0% | 5.9% |
| 净利润同比 | 235.7% | 3.9% |
| 每股收益（稀释后） | $1.58 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNXRVTY
| Q4 25 | $610.5M | $772.1M | ||
| Q3 25 | $583.8M | $698.9M | ||
| Q2 25 | $962.4M | $720.3M | ||
| Q1 25 | — | $664.8M | ||
| Q4 24 | — | $729.4M | ||
| Q3 24 | $424.2M | $684.0M | ||
| Q2 24 | $321.4M | $691.7M | ||
| Q1 24 | $384.6M | $649.9M |
净利润CNXRVTY
| Q4 25 | $196.3M | $98.4M | ||
| Q3 25 | $202.1M | $46.7M | ||
| Q2 25 | $432.5M | $53.9M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $94.6M | ||
| Q3 24 | $65.5M | $94.4M | ||
| Q2 24 | $-18.3M | $55.4M | ||
| Q1 24 | $6.9M | $26.0M |
毛利率CNXRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率CNXRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 16.3% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | — | 6.8% |
净利率CNXRVTY
| Q4 25 | 32.1% | 12.7% | ||
| Q3 25 | 34.6% | 6.7% | ||
| Q2 25 | 44.9% | 7.5% | ||
| Q1 25 | — | 6.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | 15.4% | 13.8% | ||
| Q2 24 | -5.7% | 8.0% | ||
| Q1 24 | 1.8% | 4.0% |
每股收益（稀释后）CNXRVTY
| Q4 25 | $1.58 | $0.86 | ||
| Q3 25 | $1.21 | $0.40 | ||
| Q2 25 | $2.53 | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | $0.37 | $0.77 | ||
| Q2 24 | $-0.12 | $0.45 | ||
| Q1 24 | $0.04 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $779.0K | $919.9M |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $4.3B | $7.3B |
| 总资产 | $9.1B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资CNXRVTY
| Q4 25 | $779.0K | $919.9M | ||
| Q3 25 | $4.7M | $931.4M | ||
| Q2 25 | $3.4M | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $1.3M | $1.2B | ||
| Q2 24 | $3.9M | $2.0B | ||
| Q1 24 | $2.0M | $1.7B |
总债务CNXRVTY
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.3B | — |
股东权益CNXRVTY
| Q4 25 | $4.3B | $7.3B | ||
| Q3 25 | $4.1B | $7.4B | ||
| Q2 25 | $4.1B | $7.6B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | $4.3B | $7.9B | ||
| Q2 24 | $4.3B | $7.9B | ||
| Q1 24 | $4.3B | $7.8B |
总资产CNXRVTY
| Q4 25 | $9.1B | $12.2B | ||
| Q3 25 | $8.9B | $12.1B | ||
| Q2 25 | $9.0B | $12.4B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | — | $12.4B | ||
| Q3 24 | $8.5B | $12.8B | ||
| Q2 24 | $8.6B | $13.4B | ||
| Q1 24 | $8.7B | $13.4B |
负债/权益比CNXRVTY
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.63× | — | ||
| Q2 25 | 0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | 0.53× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $297.0M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $122.6M | $161.8M |
| 自由现金流率自由现金流/营收 | 20.1% | 21.0% |
| 资本支出强度资本支出/营收 | 28.6% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.51× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $505.2M | $509.4M |
8季度趋势，按日历期对齐
经营现金流CNXRVTY
| Q4 25 | $297.0M | $182.0M | ||
| Q3 25 | $233.8M | $138.5M | ||
| Q2 25 | $282.5M | $134.3M | ||
| Q1 25 | — | $128.2M | ||
| Q4 24 | — | $174.2M | ||
| Q3 24 | $170.2M | $147.9M | ||
| Q2 24 | $191.8M | $158.6M | ||
| Q1 24 | $185.1M | $147.6M |
自由现金流CNXRVTY
| Q4 25 | $122.6M | $161.8M | ||
| Q3 25 | $158.2M | $120.0M | ||
| Q2 25 | $168.9M | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | $55.4M | $125.6M | ||
| Q2 24 | $39.8M | $136.6M | ||
| Q1 24 | $16.9M | $129.7M |
自由现金流率CNXRVTY
| Q4 25 | 20.1% | 21.0% | ||
| Q3 25 | 27.1% | 17.2% | ||
| Q2 25 | 17.6% | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | 13.1% | 18.4% | ||
| Q2 24 | 12.4% | 19.7% | ||
| Q1 24 | 4.4% | 20.0% |
资本支出强度CNXRVTY
| Q4 25 | 28.6% | 2.6% | ||
| Q3 25 | 12.9% | 2.6% | ||
| Q2 25 | 11.8% | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | 27.0% | 3.3% | ||
| Q2 24 | 47.3% | 3.2% | ||
| Q1 24 | 43.7% | 2.7% |
现金转化率CNXRVTY
| Q4 25 | 1.51× | 1.85× | ||
| Q3 25 | 1.16× | 2.97× | ||
| Q2 25 | 0.65× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | 2.60× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 27.01× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNX
| Natural Gas Reserves | $436.6M | 72% |
| Other | $66.8M | 11% |
| NG Ls | $38.1M | 6% |
| Coalbed Methane | $35.2M | 6% |
| Shale | $17.5M | 3% |
| Oil And Gas Purchased | $14.4M | 2% |
| Oil And Condensate | $1.9M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
